Dasa Cizkova
Has grant
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Recent Grants
Grant: Close
Study of functional bio-implants and stem cells for CNS regeneration (2016-2020)
Open Date: 2016-01-01
Close Date: 2020-01-01
Grant: Close
Spinal cord repair: releasing the neuron-intrinsic brake on axon regeneration
Open Date: 2016-01-01
Close Date: 2019-01-01
Grant: Close
New combination therapy based on alginate biomaterials and trophic factors for the recovery of the injured spinal cord
Open Date: 2015-01-01
Close Date: 2018-01-01
Grant: Close
BMBS COST Action BM1002 Nanomechanics of intermediate filament networks (NANONET)
Open Date: 2012-01-01
Close Date: 2016-01-01
Grant: Close
Modified biomaterials and cell therapy to support regeneration of injured spinal cord
Open Date: 2012-01-01
Close Date: 2015-01-01
Articles (11)
In recent years, many studies have focused their attention on the dog as a proper animal model for human cancer. In dogs, mammary tumors develop spontaneously, involving a complex interplay between tumor cells and the immune system and revealing several molecular and clinical similarities to human breast cancer. In this review, we summarized the major features of canine mammary tumor, risk factors, and the most important biomarkers used for diagnosis and treatment. Traditional therapy of mammary tumors in dogs includes surgery, which is the first choice, followed by chemotherapy, radiotherapy, or hormonal therapy. However, these therapeutic strategies may not always be sufficient on their own; advancements in understanding cancer mechanisms and the development of innovative treatments offer hope for improved outcomes for oncologic patients. There is still a growing interest in the use of personalized medicine, which should play an irreplaceable role in the research not only in human cancer therapy, but also in veterinary oncology. Moreover, immunotherapy may represent a novel and promising therapeutic option in canine mammary cancers. The study of novel therapeutic approaches is essential for future research in both human and veterinary oncology.
Year:
2024
Year:
2023
Year:
2023
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Collaborators (3)
Michel Salzet
Distuguish Professor (PRCE2)
Ministère de l'Éducation Nationale
Marie Duhamel
Associate professor
Université de Lille
Fabien Vanden Abeele
Université de Lille
Make your next move.
Prepare your application
Review drafts before you send them.